PofoliaShared via Pofolia

BMC Oral Health· 2026Q1

Immunohistochemical expression of BRD4 and MUC1 in Oral Lichen Planus: association with clinical subtypes and role as potential biomarkers of epithelial alteration

Zhwan Abdulla Sabri, Dena Nadhim Mohammad

Short summary

This study is the first to show BRD4 expression in oral lichen planus (OLP), finding elevated levels of both BRD4 and MUC1 in erosive OLP compared to non-erosive subtypes (n=25 OLP cases, 5 controls).

AI-generated from the title and abstract; the full text is not read.

Key points

  • BRD4 was detected in 88% of OLP cases (median H-score 120.9), primarily in basal–parabasal nuclei.
  • MUC1 was positive in 84% of OLP cases (median positivity 71%), with frequent full-thickness epithelial distribution.
  • Erosive OLP showed higher expression levels for both BRD4 and MUC1 compared to non-erosive OLP, though not statistically significant (p > 0.05).
  • A weak positive correlation (Spearman’s ρ = 0.26) was observed between BRD4 and MUC1 expression.

AI-generated from the title and abstract; the full text is not read.

Abstract

Oral lichen planus (OLP) is a chronic immune-mediated disorder recognized by the World Health Organization (WHO) as an oral potentially malignant disorder (OPMD). Differentiating inflammation-associated epithelial alterations from early dysplastic changes remains a diagnostic challenge, highlighting the need for objective molecular biomarkers. Bromodomain-containing protein 4 (BRD4) and mucin-1 (MUC1) are involved in transcriptional regulation and epithelial differentiation, respectively; however, their combined expression in OLP has not been previously investigated. A retrospective cross-sectional study was conducted on 25 formalin-fixed paraffin-embedded (FFPE) OLP cases and 5 normal oral mucosa controls. Immunohistochemical staining for BRD4 and MUC1 was performed. Nuclear expression of BRD4 and membranous/cytoplasmic expression of MUC1 were semi-quantitatively evaluated. BRD4 expression was assessed using the H-score, while MUC1 was evaluated based on percentage positivity. Associations with clinical subtypes and between markers were analyzed using non-parametric tests and effect size measures. BRD4 expression was detected in 88% of OLP cases, predominantly localized to basal–parabasal nuclei, with a median H-score of 120.9. MUC1 was positive in 84% of cases, with a median positivity of 71% and frequent full-thickness epithelial distribution (47.6%). Erosive OLP showed higher expression levels for both markers compared to non-erosive OLP, although these differences did not reach statistical significance (p > 0.05). A weak positive correlation between BRD4 and MUC1 was observed (Spearman’s ρ = 0.26), with a moderate effect size in categorical association (Cramér’s V = 0.30). This is the first study demonstrating BRD4 expression in OLP, with both BRD4 and MUC1 showing higher levels in erosive lesions. Expression patterns are more compatible with epithelial changes due to chronic inflammation than with a dysplastic transformation per se, although both processes share molecular characteristics that do not allow them to be clearly distinguished in this study. These findings are preliminary and require validation in larger prospective studies.

The authors' abstract, as published at the source. BMC Oral Health, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Periodontics

PeriodonticsDentistry